Drugmaker lobbying group sues government over plan to negotiate Medicare drug prices theitem.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theitem.com Daily Mail and Mail on Sunday newspapers.
The Pharmaceutical Research and Manufacturers of America (PhRMA), the National Infusion Center Association, and the Global Colon Cancer Association have filed a lawsuit against the Biden administration over Medicare's new powers to reduce drug prices for seniors. The Inflation Reduction Act, which allows Medicare to negotiate drug prices, has faced four lawsuits challenging its provisions. The policy is anticipated to impact the pharmaceutical industry's profits. The lawsuit argues that the Medi
PhRMA and other groups sue HHS over drug pricing provisions of the IRA healthcarefinancenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcarefinancenews.com Daily Mail and Mail on Sunday newspapers.